TY - JOUR
T1 - VLA-4 blockade suppresses endotoxin-induced uveitis
T2 - In vivo evidence for functional integrin up-regulation
AU - Hafezi-Moghadam, A.
AU - Noda, K.
AU - Almulki, L.
AU - Iliaki, E. F.
AU - Poulaki, V.
AU - Thomas, K. L.
AU - Nakazawa, T.
AU - Hisatomi, T.
AU - Miller, J. W.
AU - Gragoudas, E. S.
N1 - Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.
PY - 2007/2
Y1 - 2007/2
N2 - Leukocyte adhesion to the vascular wall is a critical early step in the pathogenesis of inflammatory diseases and is mediated in part by the leukocyte integrin, VLA-4, which binds to endothelial vascular cell adhesion molecule (VCAM) -1. Here, we investigate VLA-4's role in endotoxin-induced uveitis (EIU). At various time points (6-48 h) after EIU induction, the severity of the inflammation was evaluated by quantifying cell and protein content in the aqueous fluid, firm leukocyte adhesion in the retinal vessels, and the number of extravasated leukocytes into the vitreous. Functional activation of VLA-4 in vivo was investigated in our previously introduced autoperfused micro flow chamber assay. Firm adhesion of EIU leukocytes to immobilized VCAM-1 under physiological blood flow conditions was significantly increased compared with normal controls (P<0.05), suggesting an important role for VLA-4 in EIU. VLA-4 blockade in vivo significantly suppressed all uveitis-related inflammatory parameters studied, decreasing the clinical score by 45% (P<0.01), protein content in the aqueous fluid by 21% (P<0.01), retinal leukostasis by 68% (P<0.01), and leukocyte accumulation in the vitreous by 75% (P<0.01). Our data provide novel evidence for functional up-regulation of VLA-4 during EIU and suggest VLA-4 blockade as a promising therapeutic strategy for treatment of acute inflammatory eye diseases.
AB - Leukocyte adhesion to the vascular wall is a critical early step in the pathogenesis of inflammatory diseases and is mediated in part by the leukocyte integrin, VLA-4, which binds to endothelial vascular cell adhesion molecule (VCAM) -1. Here, we investigate VLA-4's role in endotoxin-induced uveitis (EIU). At various time points (6-48 h) after EIU induction, the severity of the inflammation was evaluated by quantifying cell and protein content in the aqueous fluid, firm leukocyte adhesion in the retinal vessels, and the number of extravasated leukocytes into the vitreous. Functional activation of VLA-4 in vivo was investigated in our previously introduced autoperfused micro flow chamber assay. Firm adhesion of EIU leukocytes to immobilized VCAM-1 under physiological blood flow conditions was significantly increased compared with normal controls (P<0.05), suggesting an important role for VLA-4 in EIU. VLA-4 blockade in vivo significantly suppressed all uveitis-related inflammatory parameters studied, decreasing the clinical score by 45% (P<0.01), protein content in the aqueous fluid by 21% (P<0.01), retinal leukostasis by 68% (P<0.01), and leukocyte accumulation in the vitreous by 75% (P<0.01). Our data provide novel evidence for functional up-regulation of VLA-4 during EIU and suggest VLA-4 blockade as a promising therapeutic strategy for treatment of acute inflammatory eye diseases.
UR - http://www.scopus.com/inward/record.url?scp=33846829412&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846829412&partnerID=8YFLogxK
U2 - 10.1096/fj.06-6390com
DO - 10.1096/fj.06-6390com
M3 - Article
C2 - 17202250
AN - SCOPUS:33846829412
SN - 0892-6638
VL - 21
SP - 464
EP - 474
JO - FASEB Journal
JF - FASEB Journal
IS - 2
ER -